BSE filing, NSE: NAVA. Summary written from the filing by ALFA Finder's alert engine.
NAVA Ltd: key numbers
- Share price
- ₹514.25
- Market cap
- ₹14,571 Cr
- Revenue (annual)
- ₹4,291 Cr
- Net profit (annual)
- ₹786.7 Cr
- P/E (TTM)
- 19.3×Sector 21.4×
- Promoter holding
- 50.03%+0.00% QoQ
- FII holding
- 9.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NAVA Ltd
All →NAVA Board Meeting Date
Nava Ltd intimated that its Board meeting is scheduled for 12 Nov 2026 to consider unaudited Q2 FY27 results. No financial figures or decisions are reported yet as the meeting has not been held.
NAVA Business Update
NAVA Limited announced a planned 30-day annual maintenance shutdown of its 150 MW Paloncha power plant. Normal operations are expected to resume within approximately 30 days.
NAVA Other Announcement
Nava Ltd disclosed that employee Bhagam Rama Rao acquired 10,000 equity shares via ESOP on 16-Oct-2026. This is a routine PIT Reg 7(2) compliance filing with no material corporate decision.
NAVA Employee Stock Options
Nava Limited allotted 23,550 equity shares upon exercise of vested RSUs to eligible employees, realizing ₹1.17 Crore from the exercise.
- Value
- ₹1.17 Cr
NAVA Other Announcement
Nava Limited submitted the RTA's certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
NAVA Promoter Selling (Off-Market)
Nava Ltd's promoter group member TRIVIKRAMA PRASAD PINNAMANENI HUF disposed of 1,01,000 equity shares via an off-market transfer. The disposal was executed under a partition deed to a relative.
Other board meeting date announcements
All →Challani Capital Board Meeting Date
Challani Capital intimated that its Board will meet on 11 Nov 2026. It proposes to approve Q1 results and noted the trading window closure.
Mirza International Board Meeting Date
Mirza International rescheduled its board meeting from November 3 to November 13, 2026, to approve financial results. The trading window stays closed till results declaration.
Biofil Chemicals & Pharmaceuticals Board Meeting Date
Biofil Chemicals intimates that its Board will meet on 14 Nov 2026 to approve unaudited Q1/H1 FY27 results. No financial figures or other material outcomes are disclosed yet.
T T Board Meeting Date
T T Ltd intimated its board will meet on 16 November 2026 to consider a share buyback. Trading window closed from 3 November 2026.
KCL Infra Projects Board Meeting Date
KCL Infra Projects scheduled its Q2 FY27 board meeting for 14 Nov 2026 to approve unaudited standalone results. No transaction or monetary figure is disclosed in this advance intimation.
Goyal Associates Board Meeting Date
Goyal Associates will hold its board meeting on 13 November 2026 to consider Q2 and half-year financial results. No other material decisions are proposed at this stage.